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Abstract
Background: Proteomic research in the field of parathyroid tissues is limited by the very small dimension of the
glands and by the low incidence of cancer lesions (1%). Formalin-fixed paraffin-embedded (FFPE) tissue specimens
are a potentially valuable resource for discovering protein cancer biomarkers. In this study we have verified the
applicability of a heat induced protein extraction from FFPE parathyroid adenoma tissues followed by a gel-based
or gel-free proteomic approach in order to achieve protein separation and identification.
Results: The best results for high quality MS spectra and parameters, were obtained by using a gel-free approach,
and up to 163 unique proteins were identified. Similar results were obtained by applying both SDS-out and SDS-
out + TCA/Acetone techniques during the gel-free method. Western blot analysis carried out with specific
antibodies suggested that the antigenicity was not always preserved, while specific immunoreactions were
detected for calmodulin, B box and SPRY domain-containing protein (BSPRY), peroxiredoxin 6 (PRDX 6) and
parvalbumin.
Conclusions: In spite of some limitations mainly due to the extensive formalin-induced covalent cross-linking, our
results essentially suggest the applicability of a proteomic approach to FFPE parathyroid specimens. From our point
of view, FFPE extracts might be an alternative source, especially in the validation phase of protein biomarkers
when a large cohort of samples is required and the low availability of frozen tissues might be constraining.
Background
Proteome analysis provides diagnostic information that
can be essential for therapeutic predictions. Recently, we
have performed a proteomic study of parathyroid glands
by using a two-dimensional electrophoresis (2-DE)/mass
spectrometry (MS)-based approach, and we have exam-
ined the global changes of the parathyroid adenoma tis-
sues protein profile compared to normal parathyroid
tissues [1]. This application has resulted in the identifi-
cation of a panel of proteins, which are differentially
expressed, and has suggested that the proteomic
approach might be useful in identifying potential bio-
markers in parathyroid carcinoma. Although the use of
fresh materials is desirable for any analytical technology,
large cohorts of fresh-frozen human tissue samples are
often difficult to acquire or might not be large enough
to accurately represent the tumor origin. For example,
in our experience, proteomic research studies in the
field of parathyroid tumors strictly depend on the avail-
ability of parathyroid tissues (i.e. very small dimension
of the glands, or low incidence of cancer lesions) both
for normal and cancer samples, prompting us to find an
alternative source of fresh and frozen tissues. Formalin
fixed paraffin embedded (FFPE) tissues, a common tis-
sue preservation technique, is routinely performed for
the preparation of samples used for pathological analy-
sis. The enormousness of the FFPE tissue blocks repre-
sents an invaluable and largely untapped resource for
testing biomarkers and discovering new ones. For this
reason, besides the use of this resource in immunohisto-
chemistry (IHC) and in situ hybridization-based analysis,
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high resolution methods and mass spectrometry-based
proteomics in order to utilize this archived material as
an alternative resource for research purposes. However,
proteins in FFPE tissue during the fixation process
undergo degradation and cross-linking, and have there-
fore long been thought to be unsuitable for MS-based
proteomics. Only in the past few years, the identification
of a few hundred or thousand proteins in FFPE tissues
has been reported [2-32]. Due to protein degradation
and cross-linking caused by formalin fixation, several
studies have been conducted to test the applicability of
other fixatives to proteomic analysis [2-26]. In these stu-
dies, proteins were extracted from ethanol-fixed [2],
Fine-FIX fixed [3] and HOPE-fixed [4] paraffin
embedded tissues and resolved by 2-DE. Protein profiles
obtained by using these formalin-free fixatives were
highly similar to those obtained by fresh-frozen tissues.
Moreover, both the duration of formalin fixation [5] and
tissue storage [6] have been taken into account to assess
the quality of the protein extracts. In order to improve
protein extraction, many protocols have been developed
to extract full-length proteins [7-11] or tryptic peptides
[11-14]. The quality and identity of full-length proteins
have been evaluated by SDS-PAGE, Western Blot
[4,8-10] and 2-DE [10,11,15], while tryptic peptides have
been identified by LC-MS/MS [6,11] or by CIEF/Nano
RLPC multidimensional peptide separation [16]. In
other studies, extracted proteins have been directly ana-
lyzed by MALDI-Imaging [14,17-19], and the results
were comparable with those obtained by MALDI-Tof
MS and nLC-MS [17]. Moreover, this strategy is suitable
for FFPE tissues conserved for a long time [18].
Recently, relative and absolute protein expressions have
been successfully estimated for quantitative proteomic
analysis [20-26]. This proteomic application appears to
be useful for biomarker discovery from FFPE tumor tis-
sues in comparison to healthy ones [24].
In this report, we utilized an easily accessible extraction
buffer coupled with a heat-induced antigen retrieval tech-
nique to obtain proteins from FFPE tissue specimens of
parathyroid adenoma. The separation of proteins
extracted from the FFPE tissues was performed by both
gel-free and gel-based proteomics. The protein identifica-
tions were validated by western blot analysis and com-
pared with those obtained with fresh-frozen tissues.
Materials and methods
Materials
Iodoacetamide (IAA), dithiothreitol (DTT), 3-[(3-Chola-
midopropyl)dimethylammonio]-1-propanesulfonate
(CHAPS), urea, thiourea, glycerol, sodium dodecyl sul-
fate (SDS), tetramethylethylenediamine (TEMED),
ammonium persulfate, glycine and 30% acrylamide-N,N,
N bisacrylamide were acquired from Applichem (Ger-
many). IPGs pH 3-10 NL, pharmalyte 3-10, dry strip
cover fluid and the enhanced chemiluminescence (ECL)
detection system were purchased from GE Health Care
Europe (Uppsala, Sweden). The SDS-out precipitation
kit was purchased from Thermo Scientific Rockford (IL,
USA). The anti-Parvalbumin, anti-PRDX-6, anti-calmo-
dulin, anti-MAPK1, and anti-beta actin specific primary
antibodies and secondary antibodies (horseradish peroxi-
dase (HRP)-conjugated) were from Santa Cruz Biotec-
nology (CA, USA). Anti-CCT-5, anti-PARK7 and anti-
BSPRY specific primary antibodies were from the
Abnova Corporation (Taiwan). All other reagents were
from standard commercial sources and were of the
highest grade available.
Protein extraction
Specimens of FFPE adenoma parathyroid tissues of five
patients with sporadic primary hyperparathyroidism
(PHPT) were collected from the tissue bank of the
pathology section of the Department of Surgery of the
University of Pisa. The study was approved by the local
Ethics Committee. All patients gave their informed con-
sent for the study. Seven to fifteen 5 μm section pieces
obtained from each patient were pooled and deparaffi-
nized in 2-5 changes of xylene for 10 min each. Then
the tissues were rehydrated through a series of graded
ethanol (100% two times, 85%, 70%) for 10 min each.
After rehydration, the tissues were resuspended in an
extraction buffer of 20 mM Tris-HCl at pH 4 containing
2% SDS and 0.2 M glycine, sonicated 3 times for 10 sec
each and incubated at 4°C for 1 hour under agitation.
The homogenates were heated at 100°C for 20 min and
successively at 60°C for 2 hours. The crude extracts
were finally clarified by centrifugation at 13000 g for 20
min at 4°C. The same procedure was performed for dif-
ferent section pieces, only changing the pH values of the
extraction buffer (pH 6 and 9). Three different extrac-
tions of pooled samples were performed at each pH
value. The protein content of the extracts was deter-
mined by RC/DC of Biorad using albumin as the stan-
dard. For the gel-free approach, the proteins from the
FFPE specimens were extracted in buffer at pH 6 as
above described. Then the protein extracts were treated
to reduce the content of SDS as described below to
obtain the SDS-free samples. An aliquot of these sam-
ples were lyophilized in a speed-vac (SDS-Out samples).
Alternatively, an aliquot of SDS-free samples was preci-
pitated using 10% (w/v) TCA and 0.05% DTT. After
incubation at 0°C for one hour, insoluble material was
pelleted at 14000 g. Pellets were washed three times
with cold pure acetone and air dried (SDS-Out + TCA/
Acetone samples). The experiments were performed in
triplicate.
Donadio et al. Proteome Science 2011, 9:29
http://www.proteomesci.com/content/9/1/29
Page 2 of 10SDS-Out precipitation kit
In order to remove the excess SDS from the samples,
the SDS-Out precipitation kit was used following the
manufacture’s instructions. Briefly, 1 volume of SDS-
Out precipitation reagent was added to 20 volumes of
sample. Then the mixture was incubated in ice for 20
min and centrifuged at 10000 g for 10 minutes at room
temperature. The supernatant was transferred to a spin
cup column and centrifuged for 1 minute at 10000 g to
clarify the supernatant. The samples were stored at -80°
C until they were used.
2-DE
2-DE was performed using the Immobiline-polyacrylamide
system as previously described [1]. For analytical gels, 150
μg of protein from each preparation was filled to 350 μl
with a rehydration buffer supplemented with 1% (v/v)
pharmalytes, and pH range from 3-10. The first dimension
was run on a non-linear wide range immobilized pH gra-
dient IPG (pH range from 3-10, 18 cm), at 16°C on an
Ettan IPGphor II apparatus (GE Health Care) according to
the procedure previously described [27]. After equilibra-
tion, the strips were applied to the top 12% SDS-PAGE
gels, and electrophoresis was performed using the PRO-
TEAN-II Multi Cell system (Bio-Rad) with constant
amperage (40 mA/gel) at 10°C until the front dye reached
the bottom of the gel. For the preparative run, 300 μgo f
protein from the extract, free from SDS, was loaded. Ana-
lytical gels were stained by using ammoniacal silver nitrate
as previously described [28]. Alternatively, a silver stain
protocol compatible with mass spectrometry analysis was
performed on the preparative gels [29]. The stained gels
were scanned with an Epson Expression 1680 Pro scanner,
and the images were analyzed with the Image-Master 2D
Platinum 6.01 (GE Health Care) software program. For
the analysis, the samples were grouped into classes
depending on the pH values. Protein spots were detected
and matched among different samples. Individual spot
volume values were obtained according to the program
instructions. The normalized protein abundance was cal-
culated as the spot intensity for an individual spot divided
by the spot intensity for all valid spots, and then reported
as a percentage of the volume.
LC-ESI-MS/MS analysis
Gel samples treatment for mass spectrometry
Fragments of the gel containing proteins of interest were
washed for 30 min with 100 μlo f5 0m Ma m m o n i u m
bicarbonate and 30% AcN. Gel pieces were then dried
for 30 minutes in a Hetovac vacuum centrifuge (HETO,
Allerod, Denmark). Dried pieces of gel were rehydrated
for 45 min at 4°C in 5-20 μl of a 50 mM ammonium
bicarbonate solution containing sequencing grade tryp-
sin at 6.25 ng/μl (Promega, Madison, WI, USA). After
overnight incubation at 37°C, gel pieces were dried in a
high vacuum centrifuge before being rehydrated by the
addition of 20 μlo fH 2O, and finally dried again. Elution
of the peptides was performed with 20 μl of 1% TFA for
20 min at room temperature with occasional shaking.
The TFA solution containing the proteins was trans-
ferred to a polypropylene tube. A second elution of the
peptides was performed with 20 μl of 0.1% TFA in 50%
AcN for 20 min at room temperature with occasional
shaking. The second TFA solution was pooled with the
first one. The volume of the pooled extracts was
reduced to 1-2 μl by evaporation under vacuum. Control
extractions (blanks) were performed using pieces of gels
devoid of proteins.
Lyophilized samples treatment for mass spectrometry
Lyophilized samples were suspended in 100 ml of distilled
water., Thirty μl of urea (6 M in 50 mM ammonium bicar-
bonate) were added to 30 μl of this solution, and the mix-
ture was incubated at 37°C for 30 min. Then, 30 μlo f
DTT (38 mM in distilled water) were added to the mix-
ture, and the reduction was carried out at 37°C for 1 h.
Alkylation was performed by adding 60 μl of iodoaceta-
mide (108 mM in 50 mM ammonium bicarbonate) during
1 hour at room temperature in the dark. Five μl of trypsin
porcine (Sigma) solution (50 ng/μl in 50 mM ammonium
bicarbonate) was added, and the digestion was proceeded
o v e r n i g h ta t3 7 ° C .T h es a mple was desalted with a C18
microspin column (Harvard Apparatus, Holliston, MA,
USA), dried, and re-dissolved in H20/CH3CN/FA 94.9/5/
0.1 before LC-ESI-MS/MS analysis.
LC-ESI-MS/MS was performed on a linear trap quad-
rupole (LTQ) Orbitrap XL from Thermo Electron (San
Jose, CA, USA) equipped with a NanoAcquity system
from Waters. Peptides were trapped on a home-made 5
μm 200 Å Magic C18 AQ (Michrom) 0.1 × 20 mm pre-
column and separated on a home-made 5 μm 100 Å
Magic C18 AQ (Michrom) 0.75 × 150 mm column with
a gravity-pulled emitter. The analytical separation was
run for 35 min using a gradient of H2O/FA 99.9%/0.1%
(solvent A) and CH3CN/FA 99.9%/0.1% (solvent B). The
gradient was run as follows: 0-13 min 95% A and 5% B,
then to 65% A and 35% B at 14 min, and 20% A and
80% B at 19 min at a flow rate of 220 nL/min. For the
MS survey scans, the orbitrap (OT) resolution was set
to 60000, and the ion population was set to 5 × 10
5
with an m/z window from 400 to 2000. For protein
identification, up to five precursor ions were selected for
collision-induced dissociation (CID). For MS/MS in the
LTQ, the ion population was set to 1 × 10e4 (isolation
width of 2 m/z), while for MS/MS detection in the OT,
it was set to 2 × 10e5 (isolation width of 4 m/z) and 1 ×
10e5 (isolation width of 2 m/z) for gel samples and lyo-
philized samples, respectively, with resolution of 7500,
first mass at m/z = 100, and maximum injection time of
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35% for CID.
Database searching and criteria for protein identification
Peak lists were generated from raw orbitrap data using
the embedded software from the instrument vendor
(extract_MSN.exe). The monoisotopic masses of the
selected precursor ions were corrected using an in-
house written Perl script [30]. The peak list files were
searched against the SwissProt/trEMBL database
(Release 15.10 of 03-Nov-2009) using Mascot (Matrix
Sciences, London, UK). Human taxonomy (98529
sequences) was specified for database searching. The
parent ion tolerance was set to 10 ppm. Variable amino
acid modifications were oxidized methionine. Trypsin
was selected as the enzyme, with one potential missed
cleavage, and the normal cleavage mode was used. The
mascot search was validated using Scaffold 3.00.03 (Pro-
teome Software, Portland, OR). Only proteins matching
with two different peptides with a minimum probability
score of 95% were considered identified.
Western blot
Western blot analysis was essentially performed as pre-
viously described [1]. Fresh/frozen tissues of PHPT
patients (n = 3) were obtained at surgery, immediately
snap frozen in liquid nitrogen, and stored at -80°C until
use. Both? Aliquots of proteins (25 μg) from FFPE
pooled tissues extracted at pH 6 and from fresh/frozen
pooled adenoma tissues were subjected to SDS-PAGE
and transferred to nitrocellulose, blocked with PBS/
tween/milk and then incubated with specific polyclonal
antibodies: anti-calmodulin (dilution 1:200), anti-PARK7
(dilution 1:200), anti-MAPK-1 (dilution 1:200), and anti-
parvalbumin a (dilution 1:200); anti-CCT-5 (5 μg/ml);
anti-b actin (dilution 1:1000), anti-BSPRY (dilution
1:500) and anti-PRDX6 (dilution 1:200). Antibody reac-
tivity was detected using HRP-conjugated anti-rabbit or
anti-mouse antibodies and visualized with a chemilumi-
nescent peroxidase substrate (ECL system).
Results
Comparing FFPE parathyroid adenoma tissues extractions
at different pH values using 2-DE
From the numerous protocols [7-11] that obtain a high pro-
tein recovery, we chose SDS detergent and the heating of
samples to favor the hydrolysis of methylene bridges, and
the addition of 200 mM glycine to serve as a formaldehyde
scavenger. It is known [7] that the pH of the buffer affects
proteins solubilization, so in order to establish an optimized
extraction method for FFPE parathyroid adenoma samples,
we tested extractions at buffer pH values of 4, 6 and 9. The
different pH values changed the quality of the protein
extracted ions depending on the physical properties of the
proteins such as the isoelectric point. Pooled samples were
processed, and yields of the proteins extracted with each
extraction buffer were determined after examining the
number of spots detected with 2-DE. The best results for
protein amounts extracted using buffer pH values of 4, 6
and 9 were 54.3, 61.4 and 17.2 μg/slice, respectively. Analy-
sis of 2-DE gels detected 158 ± 15, 186 ± 17 and 68 ± 9 (n
= 3) (mean ± SD) protein spots within a non-linear pH
range from 3 to 10 for extraction buffers having pH values
of 4, 6 and 9, respectively. The number of spots was signifi-
cantly lower than that obtained from the fresh/frozen tis-
sues as previously described by us [1], but was comparable
with that reported for other FFPE tissue extracts [11]. The
best results were obtained with extraction buffers at pH 6.
Typical 2-DE gel images of FFPE parathyroid protein
extracts are shown in Figures 1A, B and 1C. The gel
Figure 1 Representative 2-DE gel map of FFPE adenoma parathyroid tissue proteins. After deparaffinization in xylene and rehydration
through a series of graded alcohols, tissue was resuspended in 20 mM TrisHCl at pH 4 (A),6(B) or 9 (C) with 2% SDS and 0.2 M Glycine. The
homogenate was heated at 100°C for 20 min and at 60°C for 2 hours. A total of 150 μg of proteins was separated by 2-DE using 18 cm pH 3-10
NL strip and 12.5% SDS-PAGE. Proteins were detected by silver staining. The map was analyzed by Image master 2D platinum software. The gels
were performed in triplicate. The reported gel images are representative of a triplicate for each pH buffer.
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of matched spots ranging from 85 to 95%.
Liquid chromatography electrospray ionization tandem
mass spectrometry (LC-ESI-MS/MS) protein identifications
in gel-based and in gel-free proteomic approaches
Gel-Based approach
Sixteen protein spots extracted from FFPE adenoma
parathyroid tissues using buffer with pH 6 and separated
by 2DE were cut and analyzed by mass-spectrometry.
LC-ESI-MS/MS analysis identified 37 different proteins
with a 100% protein identification probability, and
among these 11 identified proteins were present in multi-
ple spots. A list of proteins identified based on estimated
gel and theoretical MW and pI, number of matched pep-
tides, best ion score, coverage percentage, and identified
peptides, is shown in additional file 1. Spot No. 12 was
not identified. Only Spots No. 2, No. 11 and No. 15 were
identified as unique proteins, while the others led to the
detection of a significant number of peptides belonging
to up to nine different proteins.
Gel-free approach
The SDS-Out + TCA/Acetone and the SDS-Out protein
extracts of FFPE parathyroid adenoma tissues were pro-
cessed by mass spectrometry. Both samples underwent tryp-
tic digestion and were directly analyzed by LC-ESI-MS/MS.
The number of proteins identified with a protein identifica-
tion probability over 95% were 95 for both SDS-Out +
TCA/Acetone (n = 3) and the SDS-Out samples (n = 3)
(additional file 2), and 28 and 40 for the separate SDS-Out
+ TCA/Acetone and SDS-Out samples, respectively (Tables
1 and 2). A list of identified proteins, MW, pI,best ion score,
matched peptides and coverage values of the best MS/MS
results are shown in Tables 1, 2 and additional file 2. The
MW of the identified proteins ranged from 8 (G-protein
gamma-12 subunit and ATP synthase subunit e) to 305 kDa
(thyroglobulin), while the pI ranged from 4.09 (calmodulin)
to 11.36 (histone H4). The best MS/MS results were deter-
mined both from the number of peptides found for each
identified protein (Figure 2A) and from the distribution of
sequence coverage for the identified proteins (Figure 2B).
High quality LC-ESI-MS/MS data were obtained, with more
than 70 proteins that were identified with at least 2 peptides
and with a sequence coverage of about of 10-20%. Figures
3A and 3B show the pie charts of functional classification
and the sub-cellular localization of all proteins identified by
gel-free methodology. Table 3 shows the 17 proteins that
were identified from FFPE tissues and that correspond to
the proteins previously found differentially expressed in the
adenoma of the fresh/frozen tissues [1].
Proteins revealed by western blot
Western blot analysis with specific antibodies was used to
verify the presence of significant proteins previously
identified [1] in parathyroid adenoma fresh/frozen tis-
sues. Both FFPE and fresh/frozen tissues samples were
analyzed by western blot. The representative immuno-
blots are shown in Figure 4. Immunoblot results showed
that peroxiredoxin 6 (PRDX6), B box and SPRY domain-
containing protein (BSPRY), and parvalbumin were pre-
sent in both the fresh/frozen and the FFPE tissues at the
expected molecular weight (MW). In contrast, the anti-
calmodulin antibody detected a clear and defined signal
at the expected MW (17 kDa) in the FFPE extracts,
whereas additional higher reactions (50 and 65 kDa) were
detected in the extracts of frozen tissues. No reactions
were found for mitogen activated protein kinase 1
(MAPK1), Parkinson disease protein 7 (PARK7), -T-com-
plex protein 1 subunit epsilon (CCT-5) and b-actin.
Discussion
Recently we have shown the applicability of a proteomic
approach to search for potential biomarkers in parathyr-
oid adenomas [1], and our findings represent a promis-
ing starting point for the discovery of novel biomarkers
in parathyroid carcinoma. However, some problems may
occur when studying parathyroid tissues by the proteo-
mic approach, such as the limited number of control
specimens and the very low prevalence of parathyroid
carcinomas (about 1%). The availability of annotated
archival tissue banks is not a resource used for biomar-
ker research, particularly in the validation phase when
l a r g es a m p l ec o h o r t sa r er e q u i r e d .T h ea p p l i c a t i o no f
proteomic methodologies to FFPE tissues is still at the
beginning stages. Many attempts were done to over-
come the limits of FFPE sample preparations (i.e.p r o -
tein cross-linking, protein degradation) to obtain a high-
throughput extraction methodology which may be
reproducible and quantitative. In the present study, pro-
tein extracts from parathyroid adenoma FFPE tissues
were achieved by treatment at a high temperature, in
the presence of a strong detergent and at different buf-
fer pH values. Separation and identification of protein
extracts were assessed by gel-based and gel-free proteo-
mic approaches. In the gel-based methodology, the yield
in terms of spot numbers resulted very low, and the
best results were obtained by using a buffer extraction
at pH 6. Based on previously published results [9-11]
where 2-DE was used to analyze FFPE tissues, we con-
firmed the difficulty in obtaining well-resolved protein
patterns, in particular for basic proteins. The MS/MS
identification of the focused protein spots generated MS
spectra of good quality with MS parameters comparable
with those derived from proteins of fresh/frozen tissues
[1]. Nonetheless, multiple identifications were found for
single spots, especially in the high molecular weight and
in the acidic regions, depending on an incomplete
retrieval of cross-links and protein proteolysis.
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ments that remain linked could be released due to tryp-
sin digestion and co-identified by MS/MS. Our study
shows the applicability of thec l a s s i c a l2 - D Em e t h o d o l -
ogy. However, the comparison between FFPE extract
images and fresh/frozen tissues (data not shown) has
suggested that this is not an optimal approach for a pro-
teomic analysis of FFPE tissues. Alternatively, we carried
out a gel-free method to analyze protein extracts. Unfor-
tunately, SDS, even in small concentrations impairs the
enzymatic digestion of proteins and is not compatible
with mass spectrometry analysis. In our study, the use
Table 1 Protein spots identified by LC-ESI-MS/MS from FFPE extracts separated by the SDS-out gel-free approach with
probability over 95%
Protein name Accession
No
Gene
Name
Theoretical Matched
peptides
Coverage
(%)
14-3-3 protein ipsilon P62258 YWHAE 29 4.63 2 9.4
2-oxoglutarate dehydrogenase E1 component, mitochondrial Q02218 OGDH 116 6.39 2 2.2
3-hydroxyisobutyrate dehydrogenase, mitochondrial P31937 HIBADH 35 8.38 2 7.1
40S ribosomal protein S5 P46782 RPS5 23 9.73 2 14
40S ribosomal protein S7 P62081 RPS7 22 10.09 2 18
60S acidic ribosomal protein P2 P05387 RPLP2 12 4.42 2 24
ADP/ATP translocase 1 P12235 SLC25A4 33 9.78 2 12
Aspartate aminotransferase, cytoplasmic P17174 GOT1 46 6.53 2 9.4
ATP synthase subunit b, mitochondrial P24539 ATP5F1 29 9.37 2 7.8
ATP synthase subunit e, mitochondrial P56385 ATP5 8 9.34 2 26
Calcium-binding mitochondrial carrier protein Aralar1 O75746 SLC25A12 75 8.57 3 4.9
Creatine kinase B-type P12277 CKB 43 5.34 3 10
Cytochrome b-c1 complex subunit Rieske-like protein 1 P0C7P4 UQCRFSL1 31 9.04 3 17
Cytochrome c oxidase subunit 4 isoform 1, mitochondrial P13073 COX4I1 20 9.52 2 16
D-3-phosphoglycerate dehydrogenase O43175 PHGDH 57 6.29 3 6.2
Decorin P07585 PE 40 8.75 2 11
Elongation factor 1-alpha 1 P68104 EEF1A1 50 9.10 2 5.2
Elongation factor 2 P13639 EEF2 95 6.41 2 2.9
Enoyl-CoA hydratase, mitochondrial P30084 ECHS1 31 8.34 2 13
Heterogeneous nuclear ribonucleoprotein H P31943 HNRNPH1 49 6.74 2 7.6
Isochorismatase domain-containing protein 2, mitochondrial Q96AB3 ISOC2 22 7.67 4 46
Keratin, type I cytoskeletal 16 P08779 KRT16 51 4.98 5 18
Keratin, type II cytoskeletal 2 epidermal P35908 KRT2 66 8.07 5 13
Keratin, type II cytoskeletal 6B P04259 KRT6B 60 8.09 3 11
L-lactate dehydrogenase B chain P07195 LDHB 37 5.71 3 10
Lumican P51884 LUM 38 6.16 4 12
Lysosome-associated membrane glycoprotein 1 P11279 LAMP1 45 9.00 2 5.0
Malate dehydrogenase, cytoplasmic P40925 MDH1 36 6.91 2 8.7
Medium-chain specific acyl-CoA dehydrogenase, mitochondrial P11310 ACADM 47 8.61 2 8.3
Mitochondrial 2-oxoglutarate/malate carrier protein Q02978 SLC25A11 34 9.92 5 18
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4 O00483 NDUFA4 9 9.42 2 25
Nucleoside diphosphate kinase Q32Q12 NME1-
NME2
33 8.70 2 6.80
Peroxiredoxin-6 P30041 PRDX6 25 6.00 3 17
Proteasome activator complex subunit 1 Q06323 PSME1 29 5.78 2 9.2
Protein kinase C inhibitor-2 Q8WYJ5 14 6.50 3 41
Pyruvate dehydrogenase E1 subunit alpha somatic form mitochondrial P08559 PDHA1 43 8.35 3 7.9
Ras-related protein Rab-1A P62820 RAB1A 23 5.93 2 13
Serotransferrin P02787 TF 77 6.81 2 4.7
Succinate dehydrogenase [ubiquinone] flavoprotein subunit,
mitochondrial
P31040 SDHA 73 7.06 2 6.6
Transitional endoplasmic reticulum ATPase P55072 VCP 89 5.14 3 5.7
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acetone precipitation to remove possible detergent resi-
dues, has led to comparable results. The efficacy of the
SDS-out treatment was confirmed from the absence of
real improvements in terms of yield and quality of MS-
MS identification after TCA precipitation, suggesting
the reliability of this kit in eliminating the anionic deter-
gent. A high number of common proteins were identi-
fied in both preparations. The discrepancies observed
could be due to several factors such as denaturation,
solubility of the proteins, accessibility of tryptic sites,
etc., which affected the number of identified peptides.
Recently, several studies have been performed using a
gel-free approach, but in the majority of cases. a large
number of protein identifications have corresponded to
a low number of identified peptides [11]. On the con-
trary, our MS data are encouraging both in the number
of identified proteins and in the quality of the MS
parameters. Over 70% of proteins were defined by a
number of peptides ≥ 2. Functional classification and
cellular localization of all 163 identified proteins showed
a homogenous distribution of extracted protein classes
and of their relative abundance comparable with those
previously reported for other tissues [9,10]. Nonetheless,
the applicability of a gel-free procedure was supported
by the retrieval of 14 of the 30 proteins previously
found, differentially expressed in parathyroid adenoma
when compared with normal tissues [1]. In this work,
we have reported that 22 of the 30 deregulated proteins
were clearly over-expressed compared to normal para-
thyroid. These recent results indicate that 10 of the 22
over-expressed proteins were detected in the gel-free
FFPE tissue extracts. This is a very interesting point
because it suggests the utility of these extracts as a
source in confirming the presence in the parathyroid
glands of potential biomarkers of parathyroid diseases.
Table 2 Protein spots identified by LC-ESI-MS/MS from FFPE extracts separated by the SDS-out + TCA/Acetone gel-free
approach with probability over 95%
Protein name Accession
No
Gene Name Theoretical Matched
peptides
Coverage
(%)
MW pI SDS-Out +TCA SDS-Out
+TCA
14-3-3 protein theta P27348 YWHAQ 28 4.68 2 9.0
14-3-3 protein zeta/delta P63104 YWHAZ 28 4.73 2 11
39S ribosomal protein L39, mitochondrial Q9NYK5 MRPL39 39 7.56 2 7.7
60S ribosomal protein L7 P18124 RPL7 29 1066 2 8.5
Adenine phosphoribosyltransferase P07741 APRT 20 5.78 3 20
Adenylate kinase 2, mitochondrial P54819 AK2 26 7.67 2 11
Aflatoxin B1 aldehyde reductase member 2 O43488 AKR7A2 40 6.70 2 9.5
Cathepsin G P08311 CTSG 29 11.19 2 11
cDNA FLJ61525, highly similar to Thyroglobulin B4E153 98 5.50 2 17
Fructose-bisphosphate aldolase A P04075 ALDOA 39 8.30 4 9.9
Fumarate hydratase, mitochondrial P07954 FH 55 8.85 2 6.3
Galectin-3-binding protein Q08380 LGALS3BP 65 5.13 2 4.4
G-protein gamma-12 subunit Q69YP5 DKFZp762E193 8 9.14 2 38
Guanine nucleotide-binding protein subunit beta-2-like 1 P63244 GNB2L1 35 7.60 2 8.8
Heat shock protein HSP 90-alpha P07900 HSP90AA1 85 4.94 2 5.1
Ig kappa chain C region P01834 IGKC 12 5.58 3 48
L-xylulose reductase Q7Z4W1 DCXR 26 8.33 2 9.4
Macrophage-capping protein P40121 CAPG 39 5.82 2 10
Mitochondrial import inner membrane translocase subunit Tim8 A O60220 TIMM8A 11 5.08 2 23
NAD(P) transhydrogenase, mitochondrial Q13423 NNT 114 8.31 2 2.5
NADH dehydrogenase [ubiquinone] iron-sulfur protein 3,
mitochondrial
O75489 NDUFS3 30 6.98 2 9.8
Poly(rC)-binding protein 1 Q15365 PCBP1 37 6.66 2 6.7
Profilin-1 P07737 PFN1 15 8.44 3 23
Puromycin-sensitive aminopeptidase P55786 NPEPPS 103 5.49 2 2.7
Sideroflexin-1 Q9H9B4 SFXN1 36 9.22 2 17
Transaldolase P37837 TALDO1 38 6.37 2 7.1
Trifunctional enzyme subunit beta, mitochondrial P55084 HADHB 51 9.45 2 4.6
Ubiquitin P62988 RPS27A 9 6.56 2 33
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Page 7 of 10Among the proteins identified, a variety of biological
functions were noted including apoptosis, electron
transport, response to biotic stimulus, catabolism, lipid
metabolism, cell organization, transport, protein meta-
bolism, signal transduction and chaperon activities.
Moreover, it is important to point out that proteins not
identified by LC/MS/MS, probably due to their low
expression, resulted detectable by western blot analysis
(i.e. BSPRY). However, MAPK1, PARK7 and CCT-5
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Figure 2 Gel-free approach: MS/MS sequence coverage and
matched peptides. Histograms representing distribution of number
of matched peptides (A) and sequence coverage (B) for proteins
identified in SDS-Out and SDS-Out + TCA/Acetone sample
preparations, respectively.
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Figure 3 Subcellular localization and molecular functions.
Subcellular localization and molecular functions of proteins
identified in FFPE adenoma tissues extracts by gel-free approaches
are represented in panels A and B, respectively. E, extracellular; C,
cytoplasmic; Mi, mitochondrial; N, nuclear; Me, membrane. B,
binding; C, catalytic; S, structural; R, transcription/regulation; T,
transport; O, other.
Table 3 Proteins identified from FFPE tissues and that
correspond to those differentially expressed in the
adenoma of the fresh/frozen tissues
Protein Name Accession
N°
Theoretical
Mr/pI
Fold
variation
adenoma
vs
normal in
fresh
frozen
tissue *
LC/MS/MS
from gel-
based (A),
gel-free
(B), or
both (C)
Voltage-
dependent anion
selective channel
protein1
P21796 31/8.6 ↑ 5.1 B
Cytochrome c
oxidase
subunit5A,
mitochondrial
P20674 17/6.3 ↑ 7.8 B
Cytochrome b-cl
complex subunit
1
P31930 53/5.9 ↓ 2.0 B
Protein S100 -
A11
P31949 12/6.6 ↑ 2.9 A
Parkinson disease
protein 7
B2R4Z1 20/6.3 ↑3.4 B
Glyceraldehyde 3-
phosphate
dehydrogenase
P04406 36/8.6 ↑ 2.5 C
Apolipoprotein A-
I precursor
P02647 31/5.6 ↓ 1.85 B
Ezrin P15311 69/5.9 ↑ 2.3 B
Parvalbumin P20472 11/4.8 ↑ 6.1 A
Serum albumin
precursor
P02768 71/5.9 ↓ 1.7 B
Serotransferrin
precursor
P02787 79/6.8 ↑ 2.1 C
Ubiquitin carrier
protein
(Fragment)
A8MUJ2 16/5.4 ↑ 4.8 A
40S ribosomal
proteín SA
P08865 33/4.8 ↓ 1.7 B
Calmodulin P62158 17/4.1 ↑3.2 B
Annexin A5 P08758 36/4.9 ↑ 2.7 B
14-3-3 zeta/delta P63104 28/4.7 ↑ 2.6 C
60 kDa heat
shock protein,
mitochondrial
precursor
P10809 61/5.7 ↑ 4.1 B
*See reference 1
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Page 8 of 10proteins were not detected in parathyroid adenoma
FFPE tissue extracts using their specific antibodies. The
lack of immunological detection of these proteins could
be related to the alteration of antigenicity in FFPE tis-
sues. Recently, the peculiarities in the antibodies reactiv-
ity of FFPE tissues have been investigated by Sompuram
et al. [31], and in addition to western blot, other anti-
gen-retrieval techniques (protein arrays, ELISA) were
tested to detect successfully the protein reactivity in the
extracts. In this respect, the choice of antibody is crucial
in obtaining the best results.
Conclusion
Overall, our results are encouraging and suggest the
applicability of the proteomic approach to study parathyr-
oid FFPE tissues. In our study, the gel-free procedure gives
the best results, and the use of the SDS-out kit is very effi-
cient to remove the anionic detergent and to obtain MS-
MS high quality parameters. In addition, these results are
comparable with those previously obtained with fresh/fro-
zen parathyroid adenoma samples and demonstrate the
potentiality to use these extracts as a source of protein
biomarkers both in the research and in the validation
phase. With this in mind, it is crucial to achieve reliable
results from a quantitative point of view. As far as protein
quantification, recent reports have been encouraging
[24,32] and indicate the feasibility to assess the differential
protein expression in the archived samples and to deter-
mine that the magnitudes of differential protein expres-
sions observed in FFPE tissue extracts are comparable to
those found in the fresh/frozen samples. We think that the
standardization of a method for quantitative proteomic
analysis of FFPE tissues is absolutely worth pursuing, and
that it could offer new opportunities in identifying-specific
biomarkers and their validation using widely available
archival samples. This is very important in our case, where
t h el o w - p r e v a l e n c eo fp a r a t hyroid carcinoma is con-
strained by the availability of fresh/frozen tissues. In the
future, we believe that the comparison between parathyr-
oid adenoma and carcinoma FFPE tissue extracts will
become realizable.
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